CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases

Biocon  /  News – Posts  /  Press Releases

Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.
  • Wed, 17-Apr-2024
  • Posted by: BIOCON
No Comments

Biocon is the first generics company to obtain approval for diabetes drug, Liraglutide, in the U.K.
  • Wed, 27-Mar-2024
  • Posted by: BIOCON
No Comments

Biocon Biologics Enters a Long-term Commercial Collaboration with Eris Lifesciences to Expand Patient Access in India
  • Thu, 14-Mar-2024
  • Posted by: BIOCON
No Comments

Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
  • Thu, 29-Feb-2024
  • Posted by: BIOCON
No Comments

Biocon Included in S&P Global Sustainability Yearbook 2024
  • Tue, 20-Feb-2024
  • Posted by: BIOCON
No Comments

Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
  • Fri, 09-Feb-2024
  • Posted by: BIOCON
No Comments

Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction
  • Thu, 08-Feb-2024
  • Posted by: BIOCON
No Comments

Oral Cancer Task Force’s Consensus Guidelines for Head & Neck Cancer Recognized Among 13 Worldwide Clinical Practice Guidelines
  • Mon, 05-Feb-2024
  • Posted by: BIOCON
No Comments

Biocon Biologics Partners with Sandoz for the Distribution of “Adalimumab BS Subcutaneous Injection [FKB]” in Japan
  • Fri, 22-Dec-2023
  • Posted by: BIOCON
No Comments

Biocon Academy Conducts its 8th Graduation Day
  • Tue, 19-Dec-2023
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>